Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Dopamine beta-hydroxylase | Starlite/ChEMBL | References |
Bos taurus | Dopamine beta-hydroxylase | Starlite/ChEMBL | References |
Homo sapiens | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | Starlite/ChEMBL | No references |
Homo sapiens | Bloom syndrome, RecQ helicase-like | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | dopamine beta-hydroxylase (dopamine beta-monooxygenase) | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | No references |
Homo sapiens | thyroid stimulating hormone receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.0322 | 0.0286 |
Echinococcus multilocularis | netrin receptor unc 5 | 0.0017 | 0.0142 | 0.0201 |
Mycobacterium tuberculosis | Probable cytochrome P450 124 Cyp124 | 0.0009 | 0.0037 | 0.5 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.2919 | 0.5526 |
Schistosoma mansoni | DNA helicase recq5 | 0.0011 | 0.0062 | 0.0025 |
Loa Loa (eye worm) | immunoglobulin I-set domain-containing protein | 0.0017 | 0.0142 | 0.0201 |
Brugia malayi | Protein kinase domain containing protein | 0.0017 | 0.0142 | 0.0201 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0322 | 0.0547 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0364 | 0.0328 |
Echinococcus multilocularis | Ankyrin | 0.0018 | 0.0143 | 0.0204 |
Onchocerca volvulus | 0.0036 | 0.0364 | 0.0695 | |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.0011 | 0.0062 | 0.0048 |
Mycobacterium tuberculosis | Probable cytochrome P450 141 Cyp141 | 0.0009 | 0.0037 | 0.5 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0014 | 0.0099 | 0.4933 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.028 | 0.3255 | 0.6172 |
Mycobacterium tuberculosis | Probable cytochrome P450 130 Cyp130 | 0.0009 | 0.0037 | 0.5 |
Mycobacterium tuberculosis | Possible cytochrome P450 126 Cyp126 | 0.0009 | 0.0037 | 0.5 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0011 | 0.0062 | 0.0048 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0315 | 0.0533 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0019 | 0.0163 | 0.0241 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.0011 | 0.0062 | 0.0048 |
Echinococcus multilocularis | bloom syndrome protein | 0.0026 | 0.0241 | 0.0392 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0017 | 0.0143 | 0.0203 |
Brugia malayi | follicle stimulating hormone receptor | 0.028 | 0.3255 | 0.6172 |
Echinococcus granulosus | ankyrin repeat and death domain containing protein | 0.0017 | 0.0142 | 0.0201 |
Schistosoma mansoni | netrin receptor unc5 | 0.0017 | 0.0142 | 0.0105 |
Onchocerca volvulus | 0.0086 | 0.0953 | 0.2544 | |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0017 | 0.014 | 0.3851 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.2919 | 0.5526 |
Mycobacterium tuberculosis | Possible cytochrome P450 135B1 Cyp135B1 | 0.0009 | 0.0037 | 0.5 |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.0016 | 0.0122 | 0.0163 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0011 | 0.0062 | 0.1703 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0364 | 0.0626 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0011 | 0.0062 | 0.0048 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0364 | 0.0328 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, N-terminal domain containing protein | 0.0227 | 0.2633 | 0.4979 |
Mycobacterium tuberculosis | Cytochrome P450 51 Cyp51 (CYPL1) (P450-L1A1) (sterol 14-alpha demethylase) (lanosterol 14-alpha demethylase) (P450-14DM) | 0.0009 | 0.0037 | 0.5 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0322 | 0.0547 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.0011 | 0.0062 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0019 | 0.0163 | 0.0241 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0322 | 0.0547 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.0011 | 0.0062 | 0.0048 |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | 0.0009 | 0.0037 | 0.5 |
Schistosoma mansoni | retinoblastoma-binding protein 4 (rbbp4) | 0.0018 | 0.0143 | 0.0107 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0019 | 0.0163 | 0.0241 |
Mycobacterium tuberculosis | Probable cytochrome P450 123 Cyp123 | 0.0009 | 0.0037 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 monooxygenase 142 Cyp142 | 0.0009 | 0.0037 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0364 | 0.0626 |
Echinococcus granulosus | netrin receptor unc 5 | 0.0017 | 0.0142 | 0.0201 |
Brugia malayi | Death domain containing protein | 0.0017 | 0.0142 | 0.0201 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0014 | 0.0099 | 0.4933 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0142 | 0.0105 |
Mycobacterium tuberculosis | Possible cytochrome P450 135A1 Cyp135A1 | 0.0009 | 0.0037 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0019 | 0.0163 | 1 |
Echinococcus granulosus | lamin | 0.0033 | 0.0322 | 0.0547 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0322 | 0.0547 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0322 | 0.0547 |
Trypanosoma brucei | cytochrome P450, putative | 0.0019 | 0.0163 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0142 | 0.0201 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0364 | 0.0328 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.0011 | 0.0062 | 0.0048 |
Mycobacterium tuberculosis | Probable cytochrome P450 138 Cyp138 | 0.0009 | 0.0037 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0322 | 0.0547 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0122 | 0.0163 |
Echinococcus granulosus | nuclear factor of activated T cells 5 | 0.0089 | 0.0991 | 0.183 |
Schistosoma mansoni | peptidylglycine monooxygenase | 0.0448 | 0.5251 | 0.5234 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0115 | 0.015 |
Echinococcus granulosus | bloom syndrome protein | 0.0026 | 0.0241 | 0.0392 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.018 | 0.0273 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0026 | 0.0241 | 0.0441 |
Mycobacterium tuberculosis | Probable cytochrome P450 144 Cyp144 | 0.0009 | 0.0037 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0019 | 0.0163 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 137 Cyp137 | 0.0009 | 0.0037 | 0.5 |
Mycobacterium tuberculosis | Cytochrome P450 121 Cyp121 | 0.0009 | 0.0037 | 0.5 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0009 | 0.0037 | 0.102 |
Echinococcus multilocularis | peptidyl glycine alpha amidating monooxygenase | 0.0448 | 0.5251 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0019 | 0.0163 | 0.0241 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0035 | 0.0348 | 0.0596 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.0086 | 0.0953 | 0.1757 |
Brugia malayi | DOMON domain containing protein | 0.0086 | 0.0953 | 0.1757 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0009 | 0.0037 | 0.5 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0322 | 0.0547 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0026 | 0.0241 | 0.0441 |
Loa Loa (eye worm) | hypothetical protein | 0.0448 | 0.5251 | 1 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.0086 | 0.0953 | 0.1757 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0019 | 0.0163 | 0.0241 |
Onchocerca volvulus | 0.0033 | 0.0322 | 0.0566 | |
Brugia malayi | DOMON domain containing protein | 0.0086 | 0.0953 | 0.1757 |
Onchocerca volvulus | 0.0033 | 0.0322 | 0.0566 | |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.002 | 0.0177 | 0.0141 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.0016 | 0.0122 | 0.0163 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0019 | 0.0163 | 1 |
Echinococcus multilocularis | lamin | 0.0033 | 0.0322 | 0.0547 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0.0364 | 1 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0011 | 0.0062 | 0.0048 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0017 | 0.0143 | 0.0203 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0061 | 0.0046 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0036 | 0.0364 | 0.0626 |
Entamoeba histolytica | recQ family helicase, putative | 0.0014 | 0.0099 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 125 Cyp125 | 0.0009 | 0.0037 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 140 Cyp140 | 0.0009 | 0.0037 | 0.5 |
Echinococcus granulosus | Ankyrin | 0.0018 | 0.0143 | 0.0204 |
Leishmania major | cytochrome p450-like protein | 0.0019 | 0.0163 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 139 Cyp139 | 0.0009 | 0.0037 | 0.5 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0221 | 0.2554 | 0.4827 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0011 | 0.0062 | 0.1703 |
Mycobacterium leprae | putative cytochrome p450 | 0.0009 | 0.0037 | 0.5 |
Onchocerca volvulus | 0.0286 | 0.3332 | 1 | |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0014 | 0.0099 | 0.4933 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0062 | 0.0048 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0448 | 0.5251 | 1 |
Schistosoma mansoni | peptidyl-glycine monooxygenase | 0.0448 | 0.5251 | 0.5234 |
Loa Loa (eye worm) | RecQ helicase | 0.0026 | 0.0241 | 0.0392 |
Echinococcus granulosus | peptidyl glycine alpha amidating monooxygenase | 0.0448 | 0.5251 | 1 |
Schistosoma mansoni | ankyrin 23/unc44 | 0.0017 | 0.0142 | 0.0105 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.0086 | 0.0953 | 0.1757 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0036 | 0.0364 | 0.0626 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0448 | 0.5251 | 1 |
Schistosoma mansoni | lamin | 0.0033 | 0.0322 | 0.0286 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0026 | 0.0241 | 0.0392 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0017 | 0.0142 | 0.0201 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0.0364 | 1 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0023 | 0.0204 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0115 | 0.015 |
Schistosoma mansoni | lamin | 0.0033 | 0.0322 | 0.0286 |
Loa Loa (eye worm) | hypothetical protein | 0.0448 | 0.5251 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0364 | 0.0626 |
Brugia malayi | Uncoordinated protein 44 | 0.0017 | 0.0142 | 0.0201 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0089 | 0.0991 | 0.183 |
Mycobacterium tuberculosis | Probable cytochrome P450 143 Cyp143 | 0.0009 | 0.0037 | 0.5 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.3331 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0364 | 0.0328 |
Mycobacterium tuberculosis | Probable cytochrome P450 132 Cyp132 | 0.0009 | 0.0037 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0143 | 0.0204 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0322 | 0.0547 |
Brugia malayi | DOMON domain containing protein | 0.0086 | 0.0953 | 0.1757 |
Echinococcus multilocularis | ankyrin repeat and death domain containing protein | 0.0017 | 0.0142 | 0.0201 |
Mycobacterium tuberculosis | Probable cytochrome P450 128 Cyp128 | 0.0009 | 0.0037 | 0.5 |
Schistosoma mansoni | DNA helicase recq1 | 0.0011 | 0.0062 | 0.0025 |
Echinococcus granulosus | death domain containing protein | 0.0017 | 0.0142 | 0.0201 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0322 | 0.0547 |
Onchocerca volvulus | 0.0086 | 0.0953 | 0.2544 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
-Log IC50 (binding) | = 5.59 | Inhibition of dopamine beta hydroxylase | ChEMBL. | 7783140 |
-Log IC50 (binding) | = 5.59 | Inhibition of dopamine beta-hydroxylase (DbetaH) in hypertensive rats when administered orally (or) intraperitoneally | ChEMBL. | 2296023 |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | = 6.309573445 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 15.84893192 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
Decrease (functional) | ND 0 mM | Mean arterial blood pressure at 4 h post drug at po dose of 50 mg/kg for the indicated number of SHR (spontaneous hypertensive rats) relative to blood pressure before dosing | ChEMBL. | 3820219 |
Decrease (functional) | = 22 mM | Mean arterial blood pressure at 4 h post drug at ip dose of 50 mg/kg for the indicated number of SHR (spontaneous hypertensive rats) relative to blood pressure before dosing | ChEMBL. | 3820219 |
Decrease in blood pressure (functional) | = 22 mmHg | Antihypertensive activity was determined by decrease in blood pressure response in spontaneously hypertensive rat was determined after intraperitoneal administration at a dose of 50 mg/kg | ChEMBL. | 3612682 |
IC50 (binding) | = 5.59 | Inhibition of dopamine beta hydroxylase | ChEMBL. | 7783140 |
IC50 (binding) | = 5.59 | Inhibition of dopamine beta-hydroxylase (DbetaH) in hypertensive rats when administered orally (or) intraperitoneally | ChEMBL. | 2296023 |
IC50 (binding) | = 5.59 | Inhibition of dopamine beta-hydroxylase (DbetaH) enzyme | ChEMBL. | 9435905 |
IC50 (binding) | = 2.6 uM | Inhibition of Dopamine beta hydroxylase in spontaneously hypertensive rats; Value ranges from 1.3-4.6 | ChEMBL. | 3612682 |
IC50 (binding) | = 2.6 uM | Inhibitory activity was determined against bovine dopamine beta-hydroxylase(DBH) | ChEMBL. | 2299645 |
IC50 (binding) | = 2.6 uM | Inhibition of Dopamine beta hydroxylase. | ChEMBL. | 3783606 |
IC50 (binding) | = 2.6 uM | Inhibitory Concentration against bovine Dopamine beta hydroxylase (DBH); Range is between (1.3-4.6) | ChEMBL. | 3820219 |
IC50 (binding) | = 2.6 uM | Inhibition of Dopamine beta hydroxylase in spontaneously hypertensive rats; Value ranges from 1.3-4.6 | ChEMBL. | 3612682 |
IC50 (binding) | = 2.6 uM | Inhibitory activity was determined against bovine dopamine beta-hydroxylase(DBH) | ChEMBL. | 2299645 |
IC50 (binding) | = 2.6 uM | Inhibition of Dopamine beta hydroxylase. | ChEMBL. | 3783606 |
IC50 (binding) | = 2.6 uM | Inhibitory Concentration against bovine Dopamine beta hydroxylase (DBH); Range is between (1.3-4.6) | ChEMBL. | 3820219 |
Increase (functional) | = 92 % | Change in DA/NE (Dopamine/Norepinephrine) ratio after oral dosing (50 mg/kg) | ChEMBL. | 3820219 |
Increase (functional) | = 95 % | Percent increase in DA/NE ratio was determined from assay of DA and NE in the mesenteric artery of spontaneously hypertensive rat after two doses of the compound for 50 mg/kg peroral administration | ChEMBL. | 3612682 |
Ki (binding) | = 55 nM | Binding affinity towards Dopamine beta hydroxylase using tyramine substrate at pH 4.5 in the absence of fumarate | ChEMBL. | 3712378 |
Ki (binding) | = 55 nM | Binding affinity towards Dopamine beta hydroxylase using tyramine substrate at pH 4.5 in the absence of fumarate | ChEMBL. | 3712378 |
Ki (binding) | = 0.0549 uM | Compound was evaluated for the inhibition of Dopamine beta hydroxylase at pH 4.5 | ChEMBL. | 3783606 |
Ki (binding) | = 0.0549 uM | Compound was evaluated for the inhibition of Dopamine beta hydroxylase at pH 4.5 | ChEMBL. | 3783606 |
Ki (binding) | = 0.344 uM | Compound was evaluated for the inhibition of Dopamine beta hydroxylase at pH 6.6 | ChEMBL. | 3783606 |
Ki (binding) | = 0.344 uM | Compound was evaluated for the inhibition of Dopamine beta hydroxylase at pH 6.6 | ChEMBL. | 3783606 |
Kis (binding) | = 0.055 uM | Inhibitor dissociation constant vs. tyramine substrate against Dopamine beta hydroxylase at pH 4.5. | ChEMBL. | 3820219 |
Kis (binding) | = 0.055 uM | Inhibitor dissociation constant vs. tyramine substrate against Dopamine beta hydroxylase at pH 4.5. | ChEMBL. | 3820219 |
Kis (binding) | = 0.088 uM | Inhibitor dissociation constant vs. tyramine substrate against Dopamine beta hydroxylase at pH 6 | ChEMBL. | 3820219 |
Kis (binding) | = 0.088 uM | Inhibitor dissociation constant vs. tyramine substrate against Dopamine beta hydroxylase at pH 6 | ChEMBL. | 3820219 |
Kis (binding) | = 0.344 uM | Inhibitor dissociation constant vs. tyramine substrate against Dopamine beta hydroxylase at pH 6.6 | ChEMBL. | 3820219 |
Kis (binding) | = 0.344 uM | Inhibitor dissociation constant vs. tyramine substrate against Dopamine beta hydroxylase at pH 6.6 | ChEMBL. | 3820219 |
logP (ADMET) | = 1.02 | Partition coefficient (logP) | ChEMBL. | 3820219 |
MAP (functional) | = 137 mmHg | In vivo evaluation ot the compound in spontaneously hypertensive rats for the mean arterial blood pressure | ChEMBL. | 3712378 |
Potency (functional) | = 0.0008 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 0.0282 um | PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)] | ChEMBL. | No reference |
Potency (functional) | = 0.0282 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom's syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM))] | ChEMBL. | No reference |
Potency (functional) | = 1.2589 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 895 ] | ChEMBL. | No reference |
Potency (functional) | = 1.2589 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.9935 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 3.9811 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (ADMET) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ] | ChEMBL. | No reference |
Potency (ADMET) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | 29.9349 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Potency (functional) | 33.8078 uM | PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 43.3517 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) | ChEMBL. | No reference |
Ratio (functional) | = 0.1 | In vivo evaluation ot the compound in spontaneously hypertensive rats for the catecholamine levels by taking the ratio of dopamine to norepinephrine | ChEMBL. | 3712378 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
8 literature references were collected for this gene.